C07K 14/675
Beta-endorphins
C07K14/675 (Beta-endorphins) appears on 54 US grants and 15 published applications in this corpus.
Search patents in C07K- Granted patents
- 54
- Published applications
- 15
- Assignees
- 22
- Inventors
- 71
- Latest grant
- 3 May 2011
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 19 | 0 |
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 5 | 0 |
| 1982 | 10 | 0 |
| 1983 | 2 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 1 |
| 2002 | 0 | 1 |
| 2003 | 2 | 1 |
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 0 | 1 |
| 2007 | 0 | 1 |
| 2008 | 1 | 4 |
| 2009 | 2 | 0 |
| 2010 | 0 | 0 |
| 2011 | 1 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis3 May 2011US 7,935,786 B2Zealand Pharma A/S
- Peptide library and screening systems30 Jun 2009US 7,553,617 B1Affymax, Inc.
- Method for extracellular production of target proteins employing OmpF in E. coli17 Feb 2009US 7,491,528 B2Korea Advanced Institute of Science and Technology
- Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis19 Aug 2008US 7,414,107 B2Zealand Pharma A/S
- Methods of treating chronic pain22 Jul 2003US 6,596,269 B1The United States of America as represented by the Department of Health and Human Services
- Methods and compositions for displaying peptide libraries8 Oct 2026US 2026/0308224 A1Board of Regents, The University of Texas System
- Plasmid dna encoding beta-endorphin, bacterial producer, analgesic agent18 Mar 2021US 2021/0077583 A1
- Caffeoylalphaneoendorphin peptide derivative and use thereof as anti-itching and anti-atopic agents28 Mar 2013US 2013/0079287 A1
- Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis22 Dec 2011US 2011/0312878 A1Zealand Pharma A/S
- Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis25 Sep 2008US 2008/0234467 A1
Most cited
By later US patents
- Chimeric peptides for neuropeptide delivery through the blood-brain barrier238US 4,801,575 AThe Regents of the University of California · 1989
- Chimeric peptides for neuropeptide delivery through the blood-brain barrier215US 4,902,505 AAlkermes, Inc. · 1990
- Peptide library and screening systems197US 5,432,018 AAffymax Technologies N.V. · 1995
- Manufacture and expression of structural genes153US 4,652,639 AAmgen Inc. · 1987
- Peptide library and screening systems94US 5,723,286 AAffymax Technologies N.V. · 1998